Controlled delivery of inhaled therapeutic agents

Journal of Controlled Release

Volumn 190, Issue , 2014, Pages 182-188

  Hickey, Anthony J ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

Aerosols; Pulmonary delivery; Spatial control; Temporal control

Indexed keywords

AEROSOLS; PHYSIOLOGY; TARGETED DRUG DELIVERY;

AEROSOL PROPERTIES; COMPREHENSIVE ASSESSMENT; CONTROLLED DELIVERY; CONTROLLED DRUG RELEASE; PULMONARY DELIVERY; SPATIAL CONTROL; TEMPORAL CONTROLS; THERAPEUTIC POTENTIALS;

CONTROLLED DRUG DELIVERY;

AMIKACIN; AMPHOTERICIN B; BRONCHODILATING AGENT; CIPROFLOXACIN; CORTICOSTEROID; PROPELLANT; AEROSOL; DELAYED RELEASE FORMULATION;

AEROSOL; ARTICLE; ASTHMA; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CRYSTALLIZATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG TRANSPORT; DRY POWDER INHALER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INHALATIONAL DRUG ADMINISTRATION; INHALER; LUNG; LUNG CLEARANCE; MAINTENANCE THERAPY; METERED DOSE INHALER; MUCOCILIARY CLEARANCE; NEBULIZER; PARTICLE SIZE; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; SOLID STATE; SURFACE TENSION; ULTRASOUND; DELAYED RELEASE FORMULATION; CLINICAL TRIAL (TOPIC); NONHUMAN;

ADMINISTRATION, INHALATION; AEROSOLS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; NEBULIZERS AND VAPORIZERS;

EID: 84906788908     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.05.058     Document Type: Review

References (71)

1. H.D.C. Smyth, and A.J. Hickey Controlled pulmonary drug delivery 2011 Springer New York
2. P.K. Gupta, and A.J. Hickey Contemporary approaches in aerosolized drug delivery to the lung J. Control. Release 17 1991 129 148
3. S. Ziffels, N.L. Bemelmans, P.G. Durham, and A.J. Hickey In vitro dry powder formulation performance considerations J. Control. Release 2014 (in press)
4. G. Sbirlea-Apiou, I. Katz, G. Caillibotte, T. Martonen, and Y. Yang Deposition mechanics of pharmaceutical particles in human airways A.J. Hickey, Inhalation aerosols, physical and biological basis for therapy Second edition 2007 Informa Health Care NY 1 30
5. N. Davies, and M.R. Feddah A novel method for assessing dissolution of aerosol inhaler products Int. J. Pharm. 255 2003 175 187 (Pubitemid 36369601)
6. A.J. Hickey, and D.C. Thompson Physiology of the airways A.J. Hickey, Pharmaceutical Inhalation Aerosol Technology Second edition 2004 Marcel Dekker NY 1 30
7. P.R. Byron Prediction of drug residence times in regions of the respiratory tract following aerosol inhalation J. Pharm. Sci. 75 1986 433 438 (Pubitemid 16083635)
8. D. Lu, and A.J. Hickey Pulmonary vaccine delivery Expert Rev. Vaccines 6 2007 213 226 (Pubitemid 46607457)
9. A.J. Hickey Summary of common approaches to pharmaceutical aerosol administration A.J. Hickey, Pharmaceutical Inhalation Aerosol Technology Second edition 2004 Marcel Dekker NY 385 421
10. T.S. Purewal, and D.J.W. Grant Metered dose inhaler technology 1998 Interpharm Buffalo Grove, IL
11. M.J. Telko, and A.J. Hickey Dry powder inhaler formulation Respir. Care 50 2005 1209 1227 (Pubitemid 46187575)
12. C.A. Dunbar, A.J. Hickey, and P. Holzner Dispersion and characterization of pharmaceutical dry powder aerosols KONA 167 1998 7 44
13. R.W. Niven, and A.J. Hickey Atomization and nebulizers A.J. Hickey, Inhalation aerosols physical and biological basis for therapy Second edition 2007 Informa Health New York, NY 253 282
14. A.J. Hickey, and P.R. Byron Effect of solution flow rate on the output of two modified commercially available jet nebulizers J. Pharm. Sci. 76 1987 338 340 (Pubitemid 17118166)
15. A.J. Hickey Methods of aerosol particle size characterization A.J. Hickey, Pharmaceutical inhalation aerosol technology Second edition 2004 Marcel Dekker NY 345 384
16. Z. Xu, and A.J. Hickey The physics of aerosol droplet and particle generation H.D.C. Smyth, A.J. Hickey, Controlled pulmonary drug delivery 2011 Springer New York 75 100
17. A.J. Hickey, and R.M. Evans Aerosol generation from propellant driven metered dose inhalers Inhalation aerosols, physical and biological basis for therapy First edition 1996 Marcel Dekker, Inc. 417 439
18. M.D. Louey, M. Van Oort, and A.J. Hickey Aerosol dispersion of respirable particles in narrow size distributions produced by jet-milling and spray-drying techniques Pharm. Res. 21 2004 1200 1206 (Pubitemid 38954204)
19. R. Vehring Pharmaceutical particle engineering via spray drying Pharm. Res. 25 2007 1000 1022
20. US Food and Drug Administration Draft Guidance for the Industry, Metered Dose inhaler (MDI and Dry Powder Inhaler (DPI) Chemistry, Manufacturing and Controls Documentation November 1998
21. United States Pharmacopoeia General chapter <601> aerosols, nasal sprays, metered dose inhalers, and dry powder inhalers 34 2011 USP Rockville, MD 218 239
22. J.P. Lodge, and T.L. Chan Cascade impactor, sampling and data analysis 1986 American Industrial Hygiene Association Akron, OH
23. J. Denyer, K. Nikander, and N.J. Smith Adaptive Aerosol Delivery (AAD(r)) technology Expert Opin. Drug Deliv. 1 2004 165 176 (Pubitemid 40297963)
24. S.R.B. Behara, I.C. Larson, P. Kippax, P.J. Stewart, and D.A.V. Morton Insight into pressure drop dependent efficiencies of dry powder inhalers Eur. J. Pharm. Sci. 46 2012 142 148 (P)
25. M.D. Louey, M.M. Van Oort, and A.J. Hickey Standardized entrainment tubes for the evaluation of pharmaceutical dry powder dispersion J. Aerosol Sci. 37 2006 1520 1531 (Pubitemid 44635527)
26. I. Gonda Targeting by deposition A.J. Hickey, Pharmaceutical inhalation aerosol technology second edition 2004 Marcel Dekker New York, NY 65 88
27. M.B. Snipes Long term retention and clearance of particles inhaled by mammalian species Crit. Rev. Toxicol. 20 2004 175 211
28. P.E. Newton Fundamental inhalation toxicology M.J. Derelanko, M.A. Hollinger, Handbook of toxicology Second edition 2002 CRC Press Boca Raton, FL 267 333
29. C. Ehrhardt, J. Fiegel, S. Fuchs, R. Abu-Dahab, U.F. Schaefer, J. Hanes, and C.-M. Lehr Drug absorption by the respiratory mucosa: cell culture models and particulate drug carriers J. Aerosol Med. 15 2002 131 139 (Pubitemid 34827526)
30. J.L. Sporty, L. Horálková, and C. Ehrhardt In vitro cell culture models for the assessment of pulmonary drug disposition Expert Opin. Drug Metab. Toxicol. 4 2008 333 345 (Pubitemid 351728510)
31. D. Cooney, M. Kazantseva, and A.J. Hickey Development of a size dependent aerosol deposition model utilizing human airway epithelial cells for evaluating aerosol drug delivery ATLA 32 2004 581 590 (Pubitemid 40321537)
32. M. Bur, H. Huwer, and C.-M. Lehr Drug transport across pulmonary epithelial cell monolayers, effect of particle size, apical liquid volume and deposition technique J. Aerosol Med. Pulm. Drug Deliv. 23 2009 119 127
33. D.J. Cooney, and A.J. Hickey Cellular response to the deposition of diesel exhaust particle aerosols onto human lung cells grown at the air-liquid interface by inertial impaction Toxicol. In Vitro 25 2011 1953 1965
34. R.B. Schlesinger Comparative deposition of inhaled aerosols in animals and humans: a review J. Toxicol. Environ. Health 1985 197 214 (Pubitemid 15002055)
35. A.J. Hickey Pulmonary drug delivery: pharmaceutical; chemistry and aerosol technology B. Wang, T. Siahaan, R.A. Soltero, Drug delivery principles and applications 2005 John Wiley and Sons 341 361
36. D.E. Geller, J. Weers, and S. Heuerding Development of an inhaled dry powder formulation of tobramycin using Pulmosphere™ technology J. Aerosol Med. Pulm. Drug Deliv. 24 2011 175 182
37. A.J. Hickey Back to the future: inhaled drug products J. Pharm. Sci. 102 2013 1165 1172
38. J. Fiegel, L. Garcia-Contreras, M. Thomas, J. VerBerkmoes, K. Elbert, A. Hickey, and D. Edwards Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin Pharm. Res. 25 2008 805 811 (Pubitemid 351661830)
39. L. Garcia-Contreras, J. Fiegel, M.J. Telko, K. Elbert, A. Hawi, M. Thomas, J. VerBerkmoes, W.A. Germishuizen, P.B. Fourie, A.J. Hickey, and D. Edwards Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model Antimicrob. Agents Chemother. 51 2007 2830 2836 (Pubitemid 47206218)
40. L. Garcia-Contreras, J.C. Sung, P. Muttil, D. Padilla, M. Telko, J.L. Verberkmoes, K.J. Elbert, A.J. Hickey, and D.A. Edwards Dry powder PA-824 aerosols for treatment of tuberculosis in guinea pigs Antimicrob. Agents Chemother. 54 2010 1436 1442
41. J.C. Sung, L. Garcia-Contreras, J.L. Verberkmoes, C.A. Peloquin, K.J. Elbert, A.J. Hickey, and D.A. Edwards Dry powder nitroimidazopyran antibiotic PA-824 aerosol for inhalation Antimicrob. Agents Chemother. 53 2009 1338 1343
42. J.C. Sung, D.J. Padilla, L. Garcia-Contreras, J.L. Verberkmoes, D. Durbin, C.A. Peloquin, K.J. Elbert, A.J. Hickey, and D.A. Edwards Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery Pharm. Res. 26 2009 1847 1855
43. C. Wang, and A.J. Hickey Isoxyl aerosols for tuberculosis treatment: preparation and characterization of particles AAPS PharmSciTech 11 2010 538 549
44. C. Wang, and A.J. Hickey Isoxyl particles for pulmonary delivery: in vitro cytotoxicity and potency Int. J. Pharm. 396 2010 99 104
45. R.S. Pillai, D.B. Yeates, I.F. Miller, and A.J. Hickey Controlled release from condensation coated respirable aerosol particles J. Aerosol Sci. 25 1994 461 477
46. R.S. Pillai, D.B. Yeates, I.F. Miller, and A.J. Hickey Controlled dissolution from wax-coated aerosol particles in canine lungs J. Appl. Physiol. 84 1998 717 725 (Pubitemid 28081128)
47. M.K. Taylor, A.J. Hickey, and M. VanOort Manufacture, characterization, and pharmacodynamic evaluation of engineered ipratropium bromide particles Pharm. Dev. Technol. 11 2006 321 336 (Pubitemid 44221686)
48. M. Bhat, and A.J. Hickey Effect of chloroquine on phagolysosomal fusion in cultured guinea pig alveolar macrophages: implications in drug delivery AAPS PharmSci 2 2000 E34
49. S. Suarez, M. Kazantseva, M. Bhat, D. Costa, and A.J. Hickey The influence of suspension nebulization or instillation on particle uptake by guinea pig alveolar macrophages Inhal. Toxicol. 13 2001 773 788 (Pubitemid 32936623)
50. P. O'Hara, and A.J. Hickey Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization Pharm. Res. 17 2000 955 961
51. V.V. Sethuraman, and A.J. Hickey Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug AAPS PharmSciTech 3 2002 E28
52. S. Suarez, P. O'Hara, M. Kazantseva, C.E. Newcomer, R. Hopfer, D.N. McMurray, and A.J. Hickey Airways delivery of rifampicin microparticles for the treatment of tuberculosis J. Antimicrob. Chemother. 48 2001 431 434 (Pubitemid 32898818)
53. S. Suarez, P. O'Hara, M. Kazantseva, C.E. Newcomer, R. Hopfer, D.N. McMurray, and A.J. Hickey Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model Pharm. Res. 18 2001 1315 1319 (Pubitemid 32846326)
54. L. Garcia-Contreras, V. Sethuraman, M. Kazantseva, V. Godfrey, and A.J. Hickey Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig J. Antimicrob. Chemother. 58 2006 980 986
55. A.J. Hickey, and P.R. Byron Preparation, characterization, and controlled release from coprecipitates of fluorescein and magnesium hydroxide J. Pharm. Sci. 75 1986 756 759 (Pubitemid 16016531)
56. L. Garcia-Contreras, T. Morcol, S.J. Bell, and A.J. Hickey Evaluation of novel particles as pulmonary delivery systems for insulin in rats AAPS PharmSci 5 2003 E9
57. A. Gibbons, D. Padilla-Carlin, C. Kelly, A.J. Hickey, C. Taggart, N.G. McElvaney, and S.A. Cryan The effect of liposome encapsulation on the pharmacokinetics of recombinant secretory leukocyte protease inhibitor (rSLPI) therapy after local delivery to a guinea pig asthma model Pharm. Res. 28 2011 2233 2245
58. D. Lu, and A.J. Hickey Liposomal dry powders as aerosols for pulmonary delivery of proteins AAPS PharmSciTech 6 2005 E641 E648
59. H. Schreier, W.C. Mobley, N. Concessio, A.J. Hickey, and R.W. Niven Formulation and in vitro performance of liposome powder aerosols S.T.P. Pharma Sci. 4 1994 38 44 (Pubitemid 24058058)
60. M.L. Sommerville, J.B. Cain, C.S. Johnson Jr., and A.J. Hickey Lecithin inverse microemulsions for the pulmonary delivery of polar compounds utilizing dimethylether and propane as propellants Pharm. Dev. Technol. 5 2000 219 230 (Pubitemid 30247103)
61. M.L. Sommerville, and A.J. Hickey Aerosol generation by metered-dose inhalers containing dimethyl ether/propane inverse microemulsions AAPS PharmSciTech 4 2003 E58
62. M.L. Sommerville, C.S. Johnson Jr., J.B. Cain, F. Rypacek, and A.J. Hickey Lecithin microemulsions in dimethyl ether and propane for the generation of pharmaceutical aerosols containing polar solutes Pharm. Dev. Technol. 7 2002 273 288 (Pubitemid 34983119)
63. P.P. DeLuca, A.J. Hickey, M. Kanke, A. Hazrati, P. Wedlund, and R. Rypacek Porous biodegradable microspheres for parenteral administration Topics in Pharmaceutical Sciences 1987 429 442
64. L.E. Masinde, and A.J. Hickey Aerosolized aqueous suspensions of poly(l-lactic acid) microspheres Int. J. Pharm. 100 1993 123 131 (Pubitemid 23316324)
65. M.P. Redmon, A.J. Hickey, and P.P. DeLuca Prednisolone-21-acetate poly(glycolic acid) microspheres: influence of matrix characteristics upon release J. Control. Release 9 1989 99 109 (Pubitemid 19188049)
66. N. Sivadas, D. O'Rourke, A. Tobin, V. Buckley, Z. Ramtoola, J.G. Kelly, A.J. Hickey, and S.A. Cryan A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins Int. J. Pharm. 358 2008 159 167
67. Y. Tian, M.E. Klegerman, and A.J. Hickey Evaluation of microparticles containing doxorubicin suitable for aerosol delivery to the lungs PDA J. Pharm. Sci. Technol. 58 2004 266 275 (Pubitemid 40704401)
68. Y. Tian, D. Parasrampuria, M. Kanke, and A.J. Hickey Manufacture and in-vitro assessment of bromsulphthalein and phenolphthalein loaded polyester microspheres Drug Dev. Ind. Pharm. 20 1994 1150 1178
69. N.P. Mortensen, P. Durham, and A.J. Hickey The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy J. Microencapsul. 2014 (in press)
70. I. Gonda Drugs administered directly to the respiratory tract: modeling of the duration of effective drug levels J. Pharm. Sci. 77 1988 340 346
71. S. Suarez, and A.J. Hickey Pharmacokinetic and pharmacodynamics aspects of inhaled therapeutic agents T. Martonen, Medical applications of computer modeling: the respiratory system 2001 WIT Press Boston 225 304